Comparative in vitro hepatic enzyme assay and species-specific TH modeling
Comparative in vitro hepatic enzyme assay and species-specific thyroid hormones modeling show that cinmethylin has no endocrine disrupting potential
Authors: N. Daguès, S. Melching-Kollmuss, I. Fegert, C. Gomes
BASF SE, Limburgerhof, Germany
Cinmethylin is a new herbicide developed for the selective pre-emergence control of many annual grass weeds. In toxicological studies, cinmethylin induces thyroid histopathological and hormone effects in the rat secondary to liver enzyme induction. To evaluate the human relevance of the thyroid effects, a comparative in vitro hepatic enzyme assay was conducted in rat and human primary hepatocytes, as recommended in the ECHA/EFSA Guidance for the identification of endocrine disruptors (EC 2018/605). Expression of Phase I (CYP) and Phase II (UGT) enzymes were measured after 7 days of exposure to cinmethylin. In addition, a physiologically-based kinetic (PBK) model has been developed to simulate cinmethylin effects on thyroid hormones homeostasis in rats and humans.
Cinmethylin induced CYP2B and CYP3A in rat and human hepatocytes, with a slightly more pronounced effect in male than in female donors for both species. Basal T4-UGT activity in human was 5 to 7 times lower than that in the rat and delta T4-UGT activity showed dose-related increases in cinmethylin-treated rat hepatocytes while no relevant changes were seen in human hepatocytes. The PBK model predicts no effect on the T3 and T4 concentrations and only a minor increase of TSH levels in human, when considering a worst-case exposure scenario unlikely to be achieved in real-life situations.
In conclusion, the interspecies comparative analysis using a combination of in vitro and in silico models allowed 1) to confirm that the thyroid changes observed in vivo in the rat exposed to cinmethylin were secondary to liver enzyme induction and 2) that this mode of action is not relevant to humans. Cinmethylin is therefore devoid of any endocrine disrupting potential.
Container closure system of a drug-device combination product
Biological evaluation and management of changes for a container closure system of a drug-device...
iVEMPS: QSAR Predicting Thyroid Receptor Disruption
iVEMPS: A High-Accuracy QSAR Predicting Thyroid Receptor Disruption as a First Step Toward...
COSMETICK digital tool
Analysis of the toxicological profiles of cosmetic ingredients and risks for cosmetic product:...
Effects of hepatic enzyme inducers on NIS, TPO and DIO1-2-3 activities
Effects of hepatic enzyme inducers on in vitro NIS, TPO, and DIO1-2-3 activitiesAudrey Baze1,...
Characterization of representative plasticizer exposures in NICU neonates
Characterization of representative plasticizer exposures in NICU neonates using non-negative...
NAMs for evaluating DART potential
New approach methodologies for evaluating DART potential: Review on state of the art,...